For: | Wang WH, Jiang CL, Yan W, Zhang YH, Yang JT, Zhang C, Yan B, Zhang W, Han W, Wang JZ, Zhang YQ. FOXP3 expression and clinical characteristics of hepatocellular carcinoma. World J Gastroenterol 2010; 16(43): 5502-5509 [PMID: 21086571 DOI: 10.3748/wjg.v16.i43.5502] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i43/5502.htm |
Number | Citing Articles |
1 |
Vlad Alexandru Gâta, Andrei Pașca, Andrei Roman, Maximilian Vlad Muntean, Dragoș Ștefan Morariu, Eduard Alexandru Bonci, Constantin Dina, Loredana Ungureanu. The Expression of Forkhead Box P3 T Regulatory Lymphocytes as a Prognostic Factor in Malignant Melanomas. International Journal of Molecular Sciences 2024; 25(12): 6377 doi: 10.3390/ijms25126377
|
2 |
Xiao Xiao, Yi Gang, Yong Gu, Lina Zhao, Jindong Chu, Jinfeng Zhou, Xiqiang Cai, Hui Zhang, Li Xu, Yongzhan Nie, Kaichun Wu, Zhiguo Liu, Daiming Fan. Osteopontin Contributes to TGF-β1 Mediated Hepatic Stellate Cell Activation. Digestive Diseases and Sciences 2012; 57(11): 2883 doi: 10.1007/s10620-012-2248-7
|
3 |
Giuseppina Brancaccio, Romina Salpini, Lorenzo Piermatteo, Matteo Surdo, Vanessa Fini, Luna Colagrossi, Marco Cantone, Arianna Battisti, Yasunori Oda, Domenico Di Carlo, Francesca Ceccherini-Silberstein, Carlo Federico Perno, Giovanni Battista Gaeta, Valentina Svicher. An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms 2021; 9(4): 752 doi: 10.3390/microorganisms9040752
|
4 |
BeeShin Tan, Matthew Anaka, Siddhartha Deb, Claudia Freyer, Lisa M. Ebert, Anderly C. Chueh, Sheren Al-Obaidi, Andreas Behren, Aparna Jayachandran, Jonathan Cebon, Weisan Chen, John M. Mariadason. FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.. Oncotarget 2014; 5(1): 264 doi: 10.18632/oncotarget.1600
|
5 |
M. Felcht, M. Heck, C. Weiss, J.C. Becker, E. Dippel, C.S.L. Müller, D. Nashan, M.M. Sachse, J.P. Nicolay, N. Booken, S. Goerdt, C.-D. Klemke. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells. British Journal of Dermatology 2012; 167(2): 348 doi: 10.1111/j.1365-2133.2012.10987.x
|
6 |
Chao Zeng, Yunhong Yao, Wei Jie, Miao Zhang, Xinrong Hu, Yi Zhao, Sen Wang, Jinbao Yin, Yulan Song. Up-regulation of Foxp3 participates in progression of cervical cancer. Cancer Immunology, Immunotherapy 2013; 62(3): 481 doi: 10.1007/s00262-012-1348-8
|
7 |
Kenichi Harada, Shinji Shimoda, Yasushi Kimura, Yasunori Sato, Hiroko Ikeda, Saya Igarashi, Xiang-Shan Ren, Hirohide Sato, Yasuni Nakanuma. Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: Molecular mechanism of IgG4 reaction in cancer tissue. Hepatology 2012; 56(1): 157 doi: 10.1002/hep.25627
|
8 |
Aswathy R. Devan, Bhagyalakshmi Nair, Manu Kanjoormana Aryan, Vijayastelar B. Liju, Joel Joy Koshy, Bijo Mathew, Arun Valsan, Hoon Kim, Lekshmi R. Nath. Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. Cancers 2023; 15(10): 2729 doi: 10.3390/cancers15102729
|
9 |
Zhongqin Gong, Jianqing Yu, Shucai Yang, Paul B.S. Lai, George G. Chen. FOX transcription factor family in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188376 doi: 10.1016/j.bbcan.2020.188376
|
10 |
Xi Ou, Guang‑Tao Zhang, Pei‑Kai Tian, Jing‑Sen Chen, Ze‑Wei Lin, Yong Xie, Ai‑Hong Wang, Xiao‑Ping Liu, Ji‑kui Liu. Forkhead box P3 gene silencing inhibits the expression of chemokines and chemokine receptors associated with cell growth, migration, and apoptosis in hepatocellular carcinoma cells. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7658
|
11 |
Kyu Yeoun Won, Hyun-Soo Kim, Ji-Youn Sung, Gou Young Kim, Juhie Lee, Yong-Koo Park, Youn Wha Kim, Jung-Ho Suh, Sung-Jig Lim. Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomas. Pathology - Research and Practice 2013; 209(12): 767 doi: 10.1016/j.prp.2013.08.010
|
12 |
Zhongqin Gong, Hao Jia, Jianqing Yu, Yi Liu, Jianwei Ren, Shengli Yang, Baoguang Hu, Liping Liu, Paul B. S. Lai, George Gong Chen. Nuclear FOXP3 inhibits tumor growth and induced apoptosis in hepatocellular carcinoma by targeting c-Myc. Oncogenesis 2020; 9(10) doi: 10.1038/s41389-020-00283-x
|
13 |
Lejia Sun, Gang Xu, Wenjun Liao, Huayu Yang, Haifeng Xu, Shunda Du, Haitao Zhao, Xin Lu, Xinting Sang, Yilei Mao. Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis. Oncotarget 2017; 8(24): 39658 doi: 10.18632/oncotarget.17340
|
14 |
Eduardo Henrique Cunha Neves Filho, Adriana Pinheiro Bezerra Pires, Rosane Oliveira de Sant'Ana, Silvia Helena Barem Rabenhorst, Carlos Gustavo Hirth, Maria Do Perpétuo Socorro Saldanha da Cunha. The association among HER2, MET and FOXP3 expression and tumor regression grading in gastric adenocarcinoma. APMIS 2018; 126(5): 389 doi: 10.1111/apm.12840
|
15 |
Eva Skarmoutsou, Valentina Bevelacqua, Fabio D' Amico, Angela Russo, Demetrios�� Spandidos, Aurora Scalisi, Grazia Malaponte, Claudio Guarneri. FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3618
|
16 |
Kyu Yeoun Won, Hyung Kyung Kim, Gou Young Kim, Min Jeong Song, Sung-Jig Lim. Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung. Pathology - Research and Practice 2020; 216(7): 153003 doi: 10.1016/j.prp.2020.153003
|
17 |
Xiaoning Zhang, Lifen Gao, Xiaohong Liang, Min Guo, Rong Wang, Yingfang Pan, Peng Liu, Feng Zhang, Chun Guo, Faliang Zhu, Chunfeng Qu, Chunhong Ma. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes. Liver International 2015; 35(3): 1087 doi: 10.1111/liv.12642
|
18 |
Chun Li, Liwei Sun, Rui Jiang, Peng Wang, Haogang Xue, Yudong Zhan, Xiaodong Gai. Downregulation of FOXP3 inhibits cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma. Pathology - Research and Practice 2017; 213(10): 1251 doi: 10.1016/j.prp.2017.09.004
|
19 |
Luisa Roade, Mar Riveiro-Barciela, Maria Pfefferkorn, Sara Sopena, Adriana Palom, Marta Bes, Ariadna Rando-Segura, Rosario Casillas, David Tabernero, Francisco Rodríguez-Frías, Thomas Berg, Rafael Esteban, Florian van Bömmel, María Buti. HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers. JHEP Reports 2023; 5(10): 100842 doi: 10.1016/j.jhepr.2023.100842
|
20 |
M Yoshii, H Tanaka, M Ohira, K Muguruma, T Iwauchi, T Lee, K Sakurai, N Kubo, M Yashiro, T Sawada, K Hirakawa. Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach. British Journal of Cancer 2012; 106(10): 1668 doi: 10.1038/bjc.2012.141
|
21 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3007 doi: 10.1007/978-3-319-26956-6_167
|
22 |
Xuejun Xiao, Yang Wu, Fang Shen, Yusufu MuLaTiAize, Nabi Xinhua, Xueliang Wu. Osimertinib Improves the Immune Microenvironment of Lung Cancer by Downregulating PD-L1 Expression of Vascular Endothelial Cells and Enhances the Antitumor Effect of Bevacizumab. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1531353
|
23 |
BeeShin Tan, Andreas Behren, Matthew Anaka, Laura Vella, Jonathan Cebon, John M. Mariadason, Weisan Chen. FOXP3 is not mutated in human melanoma. Pigment Cell & Melanoma Research 2012; 25(3): 398 doi: 10.1111/j.1755-148X.2012.00993.x
|
24 |
Lei Zhao, Yaming Cao. PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8843146
|
25 |
Hyunseong Kim, Dong June Keum, Jung won Kwak, Hwan-Suck Chung, Hyunsu Bae, Bruno Lomonte. Bee Venom Phospholipase A2 Protects against Acetaminophen-Induced Acute Liver Injury by Modulating Regulatory T Cells and IL-10 in Mice. PLoS ONE 2014; 9(12): e114726 doi: 10.1371/journal.pone.0114726
|
26 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_167-1
|
27 |
Ersin Akgöllü. Evaluation of Forkhead Box P3 gene polymorphisms in chronic HBV infection. The Journal of Gene Medicine 2020; 22(6) doi: 10.1002/jgm.3172
|
28 |
Wanting Shi, Kang Li, Yonghong Zhang. Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1185142
|
29 |
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Nima Rezaei, Fatemeh Fallah, Davood Bashash. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies. Cell Biochemistry and Function 2024; 42(5) doi: 10.1002/cbf.4098
|
30 |
G-F Ma, Q Miao, Y-M Liu, H Gao, J-J Lian, Y-N Wang, X-Q Zeng, T-C Luo, L-L Ma, Z-B Shen, Y-H Sun, S-Y Chen. High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment. British Journal of Cancer 2014; 110(6): 1552 doi: 10.1038/bjc.2014.47
|
31 |
Kenichi Harada, Yasuni Nakanuma. Cholangiocarcinoma with respect to IgG4 Reaction. International Journal of Hepatology 2014; 2014: 1 doi: 10.1155/2014/803876
|
32 |
Joselyn Rojas, Guillermo Teran-Angel, Luisa Barbosa, Darrell L. Peterson, Lisbeth Berrueta, Siham Salmen. Activation-dependent mitochondrial translocation of Foxp3 in human hepatocytes. Experimental Cell Research 2016; 343(2): 159 doi: 10.1016/j.yexcr.2016.04.008
|
33 |
Yang Deng, La Wang, Yingjie Zhang, Dandan Sun, Hang Min, Hao Zhou, Chengchen Xu, Na Xu, Fengwu Qiu, Jingjiao Zhou, Jun Zhou. HBx promotes hepatocellular carcinoma progression by repressing the transcription level of miR-187-5p. Aging 2023; doi: 10.18632/aging.204921
|
34 |
Gui-Fen Ma, Shi-Yao Chen, Zhi-Rong Sun, Qing Miao, Yi-Mei Liu, Xiao-Qing Zeng, Tian-Cheng Luo, Li-Li Ma, Jing-Jing Lian, Dong-Li Song. FoxP3 inhibits proliferation and induces apoptosis of gastric cancer cells by activating the apoptotic signaling pathway. Biochemical and Biophysical Research Communications 2013; 430(2): 804 doi: 10.1016/j.bbrc.2012.11.065
|
35 |
Lujuan Han, Suli Dai, Zhirong Li, Cong Zhang, Sisi Wei, Ruinian Zhao, Hongtao Zhang, Lianmei Zhao, Baoen Shan. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1498-z
|
36 |
Xiaoqin Zheng, Wenjie Jin, Shanshan Wang, Huiguo Ding. Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.729705
|